Hematology 2017: CME/MOC Tests

Hematology 2017: CME/MOC Tests
CME
MOC

The CME/MOC Tests are divided into two subtests, one focused on malignant hematology content and one focused on non-malignant content. Successful completion of each test earns the participant 20 AMA PRA Category 1 Credits™. Participants claim CME credits and/or ABIM MOC points for each test individually and can take one or both tests, depending on their CME and MOC needs.

Hematology 2017: Malignant Test
The Hematology 2017: Malignant Test is a 25-question module worth 20 CME credits or ABIM MOC points. 

These knowledge-based questions cover content from the 2017 ASH Education Program Sessions on: 

Acute Lymphocytic Leukemia: New Approaches in Management
Acute Myeloid Leukemia: How Can We Improve Upon "Standard" Therapy?
Ham-Wasserman Lecutre on AL Amyloidosis: From Molecular Mechanisms to Targeted Therapies
Chronic Myeloid Leukemia:  Where are We in the Current TKI Era?
Controversies in Myeloma
Dilemmas in Pediatric Hematological Malignancy
Evolving Strategies in Aggressive B-Cell Lymphoma 
Hodgkin Lymphoma: New Insights, New Approaches
Individualizing Therapy in Chronic Lymphocytic Leukemia
Indolent Lymphoma: How Understanding Disease Biology is Influencing Clinical Decision-Making
Myelodysplastic Syndrome: Understanding the Current Treatment Landscape
Myeloproliferative Neoplasms: New Insights in the Current Treatment Paradigm
Novel Therapeutics in Myeloma
The Challenge of Primary and Secondary Central Nervous System Lymphoma
The Expanding Role of Immunotherapy in Non-Hodgkin Lymphoma
When Graft versus Tumor Fails: The Biology and Treatment of Relapse after Allogeneic Stem Cell Transplantation

Hematology 2017: Non-Malignant Test
The Hematology 2017: Non-Malignant Test is a 25-question module worth 20 CME credits or ABIM MOC points.

These knowledge-based questions cover content from the 2017 ASH Education Program Sessions on:

Bone Marrow Failure: Acquired
Bone Marrow Failure: Inherited
Common Clinical Questions in Cancer-Associated Venous Thromboembolism
Common Hematologic Consults in Pregnancy
Congenital and Acquired Neutropenia
Controversies in Venous Thromboembolism: To Treat or Not to Treat
It All Starts Here: Disorders of Primary Hemostasis
Lessons Learned from Quality Improvement Initiatives in Sickle Cell Disease
Emerging Issues in Clinical Care in Thalassemia
Management of Sickle Cell Disease: Present and Future
Practical Aspects of Acute and Chronic Pain Management in Sickle Cell Disease
The Changing Landscape of Hemophilia Therapy
Therapeutic Apheresis as an Immunomodulatory Tool
Thrombocytopenia in Hospitalized Patients

Pricing

Purchase Options Resident/Graduate
Medical Student Member
US/International
Associate Member
Members Non-Members
Hematology 2017: CME/MOC Tests $75.00 $75.00 $75.00 $75.00